May’s seed/venture-stage investments combine to £5m total

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Welcome to our monthly feature focussing on the Scottish investment sector, brought to you in partnership with Beauhurst, the platform that shares rich information on UK based high-growth companies.

Eight seed/venture-stage investments took place in the month of May with eight different investors taking part.

The eight deals raised a combined total of £5m with all the companies in the seed/venture-stage, with 50/50 split between seed and venture-stage.

Here is a break down of all eight deals –

1. Pharmacells

Pharmacells has developed products to store stem cells for individual consumers and identify and remove dead cells from cultures.

Deal amount: £1.25m
Date: 24/05/2017

Investors: Unknown as yet (this is an unannounced deal, uncovered by Beauhurst research). Previous investors include Equity Finance, managed by UK Steel Enterprise, who invested £100k in 2013.

Notes: This deal put the company’s valuation at £18.4m pre-money, an increase from £15.8m last January. The company is also trading as Precious Cells.

Read more – [insert page=’science-firm-plans-1-2m-expansion-and-job-creation’ display=’link’]

2. Metix

Metix has developed a hand-held diagnostic device that is resistant to outdoor conditions and monitors vital signs, including blood pressure, respiratory rate and temperature.

Deal amount: £1.2m
Date: 24/05/2017

Investors: Deepbridge Life Sciences, Scottish Investment Bank, SMART Scotland: Research & Development Projects. The latter two funds are both managed by Scottish Enterprise.

Notes: This raise puts the company at £2.36m, although Beauhurst has only been able to verify £744k of the investment: it is possible that more funding is set to follow later, or that some of it was in the form of debt finance.

Read more – [insert page=’patient-monitoring-technology-secures-1-2m-funding’ display=’link’]


3. Edinburgh Molecular Imaging

Edinburgh Molecular Imaging (EMI) is developing optical molecular imaging technology to help diagnose and monitor a range of respiratory diseases.

Deal amount: £1m
Date: 26/05/2017

Investors: Unknown as yet (this is an unannounced deal, as above).

Notes: This raise puts the company at £5.5m pre-money, an increase of £1.25m from April 2016. Previous investors include Epidarex Capital and the Scottish Venture Fund. The company has also secured a £150k Health & Life Science grant from Innovate UK.

Read more – [insert page=’em-imaging-obtains-global-licence-for-optical-agent-that-detects-cancer-early’ display=’link’]

4. NCTech

NCTech has developed and manufactures a 360 degree panoramic camera.

Deal amount: £750k
Date: 18/05/2017

Investors: Unknown as yet (this is an unannounced deal, as above).

Notes: The investment puts the company at £8.75m, an increase of £0.75m from its raise six months ago. Previous investors include the Scottish Investment Bank, Innovation Finance, and Archangels; the company has also secured two Innovate UK grants.

Read more – [insert page=’google-pilot-new-360-degree-camera-edinburgh-firm’ display=’link’]

5. Care Sourcer

Care Sourcer operates an online platform that allows users to browse for and connect with appropriate carers and care homes.

Deal amount: £500k
Date: 09/05/2017

Investors: Accelerated Digital Ventures, BGF Ventures

Notes: This was only Care Sourcer’s second raise (taking its total raised to £525k). It has also secured a £25k grant from Scottish EDGE (Dec 2016).

Read more – [insert page=’scottish-health-tech-startup-wins-nhs-contract’ display=’link’]

6. Organised Health

Organised Health develops software that allows patients to manage their own medication, and technology that dispenses it without the need for a present pharmacist.

Deal amount: £150k
Date: 10/05/2017

Investors: Business angel(s)

Notes: A raise (£30k) seven months ago valued the young company at £600k. Prior to that it acquired Universal Pharmacy, a small company that provided pharmaceuticals to care homes and individuals. Previous investors include Shawbrook Business Finance.

Read more – [insert page=’organised-health-secures-150k-investment-prescription-delivery-platform’ display=’link’]

7. Kajeka

Kajeka, a spin-out of the University of Edinburgh, has developed a software called Miru that is capable of efficiently analysing and plotting large amounts of data from a variety of sources. The company claims that its software can be used by both experienced data analysts and non-specialists.

Deal amount: £87.4k
Date: 17/05/2017

Investors: Unannounced deal

Notes: Kajeka’s second fundraising, this takes it to £180k raised in total. This valued it at £379k, up from £273k two years ago.


8. Silver Cloud

Silver Cloud provides SMEs and large corporations with a variety of office software, hardware and telecommunications services, including landlines, broadband, photocopiers and printers.

Deal amount: £50k
Date: 26/05/2017

Investors: Unannounced deal

Notes: Silver Cloud’s first ever raise, this deal values it at £952k.

Beauhurst is a platform where you can access rich information on UK high-growth companies.


Related News